Remus Pharmaceuticals Limited (NSE:REMUS)
India · Delayed Price · Currency is INR 764.05
+3.20 (0.42%)
May 25, 2026, 9:48 AM IST
Remus Pharmaceuticals Market Cap
Remus Pharmaceuticals has a market cap or net worth of 8.87 billion as of May 22, 2026. Its market cap has decreased by -20.92% in one year.
Market Cap
8.87B
Enterprise Value
9.20B
Revenue
8.60B
Ranking
n/a
PE Ratio
19.41
Stock Price
764.05
Market Cap Chart
Since May 29, 2023, Remus Pharmaceuticals's market cap has increased from 2.65B to 8.87B, an increase of 235.14%. That is a compound annual growth rate of 49.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 8.87B | 8.35% |
| Dec 31, 2025 | 8.19B | -44.37% |
| Dec 31, 2024 | 14.72B | 30.53% |
| Dec 29, 2023 | 11.27B | 325.95% |
| May 29, 2023 | 2.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Accent Microcell | 9.18B |
| Infinium Pharmachem | 3.30B |
| Quest Laboratories | 1.77B |
| Sotac Pharmaceuticals | 1.23B |
| Vilin Bio Med | 676.58M |
| Zenith Drugs | 667.95M |
| Medicamen Organics | 286.07M |
| Sunrest Lifescience | 158.77M |